Legislation That May Impact Specialty Pharmacy

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses government action that could influence specialty pharmacy.

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses government action that could influence specialty pharmacy.

Related Videos
Senior Male Research Scientist is Using a Tablet Computer in a Modern High-Tech Laboratory. Genetics and Pharmaceutical Studies and Researches | Image Credit: Gorodenkoff - stock.adobe.com
Acute psoriasis on the elbows is an autoimmune incurable dermatological skin disease. Large red, inflamed, flaky rash on the knees. Joints affected by psoriatic arthritis | Image Credit: SNAB - stock.adobe.com
Portrait of a smiling female pharmacist, male colleague working with drugs in the background. | Image Credit: bnenin - stock.adobe.com
Dermatologist examining the skin of a patient | Image Credit: thodonal - stock.adobe.com
Patient with cancer receiving an infusion | Image credit: RFBSIP - stock.adobe.com
Stack of files and gavel | Image credit: BillionPhotos.com - stock.adobe.com
Public Health Matters podcast logo
Cancer patient with IV | Image credit: Monkey Business - stock.adobe.com
Capitol Building | Image credit: lazyllama - stock.adobe.com
Related Content

FDA Grants Full Approval to Merck’s Keytruda for MSI-H/dMMR Solid Tumors

March 31st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Three Key Services Pharmaceutical Manufacturers Provide Patients: Are You Taking Advantage?

March 30th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

AbbVie’s Upadacitinib Meets Primary Endpoint for Systemic Lupus Erythematosus

March 28th 2023

The Rise of Health System Specialty Pharmacy Remote Call Centers: Out of Office…For Good?

March 28th 2023

FDA Grants Full Approval to Merck’s Keytruda for MSI-H/dMMR Solid Tumors

March 31st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Three Key Services Pharmaceutical Manufacturers Provide Patients: Are You Taking Advantage?

March 30th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

AbbVie’s Upadacitinib Meets Primary Endpoint for Systemic Lupus Erythematosus

March 28th 2023

The Rise of Health System Specialty Pharmacy Remote Call Centers: Out of Office…For Good?

March 28th 2023

FDA Grants Full Approval to Merck’s Keytruda for MSI-H/dMMR Solid Tumors

March 31st 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Three Key Services Pharmaceutical Manufacturers Provide Patients: Are You Taking Advantage?

March 30th 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

AbbVie’s Upadacitinib Meets Primary Endpoint for Systemic Lupus Erythematosus

March 28th 2023

The Rise of Health System Specialty Pharmacy Remote Call Centers: Out of Office…For Good?

March 28th 2023
© 2023 MJH Life Sciences

All rights reserved.